Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy

Epilepsia

Volumn 48, Issue 4, 2007, Pages 674-683

  Soranzo, Nicole ^a   Kelly, Libusha ^d   Martinian, Lillian ^a   Burley, Mari Wyn ^b   Thom, Maria ^a   Sali, Andrej ^d   Kroetz, Deanna L ^d   Goldstein, David B ^c   Sisodiya, Sanjay M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiepileptic; Drug transporter; Genetic association; RLIP76; Tagging SNPs

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTICONVULSIVE AGENT;

AMINO ACID SEQUENCE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; ENDOTHELIUM; ENZYME ACTIVITY; EPILEPSY; FLUORESCENCE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RLIP76 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTICONVULSANTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; CARBAMAZEPINE; DRUG RESISTANCE, MULTIPLE; EPILEPSY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GTPASE-ACTIVATING PROTEINS; HAPLOTYPES; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PHARMACOGENETICS; PHENOTYPE; PHENYTOIN; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 34247104934     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.00926.x     Document Type: Article

References (37)

1. Ambudkar SV, Kim IW, Sauna ZE. (2006) The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). European Journal of Pharmaceutical Sciences 27: 392-400.
2. Aronica E, Gorter JA, Van Vliet EA, Spliet WG, Van Veelen CW, Van Rijen PC, Leenstra S, Ramkema MD, Scheffer GL, Scheper RJ, Sisodiya SM, Troost D. (2003) Overexpression of the human major vault protein in gangliogliomas. Epilepsia 44:1166-1175.
3. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neuroscience 27:6:61-72.
4. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Research 56:3010-3020.
5. Berg AT, Kelly MM. (2006) Defining intractability: comparisons among published definitions. Epilepsia 47:431-436.
6. Brandt C, Bethmann K, Gastens A, Loscher W. (2005) Resistance to antiepileptic drug treatment can be counteracted by inhibition of P-glycoprotein in a rat model of temporal lobe epilepsy. Epilepsia 46:(Suppl. 6): 58.
7. Cerveny L, Pavek P, Malakova J, Staud F, Fendrich Z. (2006) Lack of interactions between breast cancer resistance protein (bcrp//abcg2) and selected antiepileptic agents. Epilepsia 47:461-468.
8. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. (2004) The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins Introduction. Pfl̈ugers Archiv: European Journal of Physiology 447:465-468.
9. Hulo N, Bairoch A, Bulliard V, Cerutti L, De Castro E, Langendijk-Genevaux PS, Pagni M, Sigrist CJ. (2006) The prosite database. Nucleic Acids Research 34: D227-30.
10. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. (2001) Predicting trans- membrane protein topology with a hidden Markov model: application to complete genomes. Journal of Molecular Biology 305:567-580
11. Kusuhara H, Sugiyama Y. (2005) Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2:73-85.
12. Kwan P, Brodie MJ. (2005) Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46:224-235.
13. Loscher W, Potschka H. (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86-98.
14. Moller S, Croning MD, Apweiler R. (2001) Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17:646-653
15. Navratil E, Couvelard A, Rey A, Henin D, Scoazec JY. (1997) Expression of cell adhesion molecules by microvascular endothelial cells in the cortical and subcortical regions of the normal human brain: an immunohistochemical analysis. Neuropathology and Applied Neurobiology. 23:68-80.
16. Owen A, Pirmohamed M, Tettey JN, Morgan P, Chadwick D, Park BK. (2001) Carbamazepine is not a substrate for P-glycoprotein. British Journal of Clinical Pharmacology 51:345-349.
17. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. (2004) UCSF Chimera - A Visualization System for Exploratory Research and Analysis. Journal of computational chemistry 25: 1605-1612.
18. Pieper U, Eswar N, Davis FP, Braberg H, Madhusudhan MS, Rossi A, Marti-Renom M, Karchin R, Webb BM, Eramian D, Shen MY, Kelly L, Melo F, Sali A. (2006) MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Research 34: D291-5.
19. Rittinger K, Walker PA, Eccleston JF, Smerdon SJ, Gamblin SJ. (1997). Structure at 1.65 a of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 389: 758-762.
20. Scheffer GL, Scheper RJ. (2002) Drug resistance molecules: lessons from oncology. Novartis Foundation Symposia 243:19-31.
21. Schmidt D, Loscher W. (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46:858-877.
22. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. New England Journal of Medicine 348:1442-1448
23. Sisodiya SM, Soranzo N, Wood NW, Goldstein DB. (2005) Association of genetic loci: replication or not, that is the question. Neurology 64:1989.
24. Sisodiya SM, Bates SE. (2006) Treatment of drug resistance in epilepsy: one step at a time. Lancet Neurology 5:380-381.
25. Sisodiya SM, Martinian L, Scheffer GL, Van der Valk P, Cross JH, Scheper RJ, Harding BN, Thom M. (2003) Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia 44:1388-1396.
26. Sisodiya SM, Martinian L, Scheffer GL, Van der Valk P, Scheper RJ, Harding BN, Thom M. (2006) Vascular colocalization of Pglycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies. Neuropathology and Applied Neurobiology 32:51-63.
27. Sisodiya SM. (2003) Mechanisms of antiepileptic drug resistance. Current Opinions in Neurology 16:197-201.
28. Soranzo N, Goldstein DB, Sisodiya SM. (2005) The role of common variation in drug transporter genes in refractory epilepsy. Expert Opinion on Pharmacotherapy 6:1305-1312.
29. Tan NC, Heron SE, Scheffer IE, Pelekanos JT, McMahon JM, Vears DF, Mulley JC, Berkovic SF. (2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63:1090-1092.
30. Tusnady GE, Simon I. (2001) The hmmtop transmembrane topology prediction server. Bioinformatics 17:849-850.
31. Tusnady GE, Sarkadi B, Simon I, Varadi A. (2006) Membrane topology of human ABC proteins. FEBS Letters 580:1017-1022.
32. van Vliet EA, Van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ, Marchi N, Vezzani A, Gorter EA. (2006) Inhibition of the multidrug transporter P-glycoprotein by XR9576 improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47:672-680.
33. Volk H, Potschka H, Loscher W. (2005) Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables. J Histochem Cytochem. 53:517-531.
34. Weale M, Goldstein DB. (2005) TagIT User Guide - Version 3.0. Weale ME, Depondt C, Macdonald SJ, Smith A, Lai PS, Shorvon SD, Wood NW, Goldstein DB(2003). Selection and evaluation of tagging SNPs in the neuronal-sodium- channel gene SCN1A: implications for linkage-disequilibrium gene mapping. American Journal of Human Genetics 73:551-565.
35. Weiss J, Kerpen CJ, Lindenmaier H, Dormann SM, Haefeli WE. (2003) Interaction of antiepileptic drugs with human P-glycoprotein in vitro. The Journal of Pharmacology and Experimental Therapeutics. 307:262-267.
36. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S, Geer LY, Helmberg W, Kapustin Y, Kenton DL, Khovayko O, Lipman DJ, Madden TL, Maglott DR, Ostell J, Pruitt KD, Schuler GD, Schriml LM, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Suzek TO, Tatusov R, Tatusova TA, Wagner L, Yaschenko E. (2006) Database resources of the national center for biotechnology information. Nucleic Acids Research 34(Database issue):D173-80
37. Zhao JH, Curtis D, Sham PC. (2000) Model-free analysis and permutation tests for allelic associations. Human Heredity 50:133-139.